Ehab Tousson

3.2k citations
154 papers · 2.3k indexed · h-index 28

Ehab Tousson

147 papers receiving 2.2k citations

Peers

Ehab Tousson
Comparison fields: 5 of 120
  • Pharmacology 393
  • Molecular Medicine 209
  • Complementary and alternative medicine 316
  • Endocrinology, Diabetes and Metabolism 371
  • Biochemistry 119
Replace Osama M. Ahmed with:
Osama M. Ahmed Egypt
Akram Eidi Iran
Debasish Bandyopadhyay India
Azar Hosseini Iran
Hanaa H. Ahmed Egypt
Mustafa Erboğa Türkiye
Yangha Kim South Korea
Vahid Reza Askari Iran
Osman Çiftçi Türkiye
Cevat Aktaş Türkiye
Ehab Tousson relative to Osama M. Ahmed Egypt Osama M. Ahmed's profile →
Citations per field
00.5×1.5×1.8×
Osama M. Ahmed · 1×
Citations per year

Countries citing papers authored by Ehab Tousson

Since Specialization
Citations

This map shows the geographic impact of Ehab Tousson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ehab Tousson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ehab Tousson more than expected).

Fields of papers citing papers by Ehab Tousson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ehab Tousson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ehab Tousson. The network helps show where Ehab Tousson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ehab Tousson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ehab Tousson Line = papers co-authored together Ehab Tousson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20251
3 20244
4 20242
5 20247
6 20238
7 202314
8 20238
9 202117
10 202121
11 201911
12 201852
13 20155
14 20158
15 201412
16 20147
17 201427
18 201426
19 201429
20 201410

About Ehab Tousson

Ehab Tousson is a scholar working on Pharmacology, Complementary and alternative medicine and Molecular Medicine, having authored 154 papers that have together received 2.3k indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (22 papers), Chemotherapy-induced organ toxicity mitigation (15 papers), Thyroid Disorders and Treatments (14 papers), Curcumin's Biomedical Applications (13 papers), Moringa oleifera research and applications (10 papers), Hormonal and reproductive studies (10 papers), Biochemical effects in animals (9 papers) and Ginkgo biloba and Cashew Applications (9 papers). The work is most often cited by research in Pharmacology (393 citations), Molecular Medicine (209 citations) and Complementary and alternative medicine (316 citations). Ehab Tousson has collaborated with scholars based in Egypt, Saudi Arabia and Iraq. Frequent co-authors include Wafaa Ibrahim, Thanaa A. El‐Masry, Ehab M. M. Ali, Hilmar Meissl, Ezar Hafez, Rehab M. Elgharabawy, Ibrahim El Tantawy El Sayed, Mohammed A. Mansour, Afrah F. Salama and Mabrouk Attia Abd Eldaim. Their work appears in journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026